CAMERO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 979
EU - Europa 509
AS - Asia 246
AF - Africa 13
SA - Sud America 4
OC - Oceania 2
Totale 1.753
Nazione #
US - Stati Uniti d'America 975
IT - Italia 311
SG - Singapore 139
SE - Svezia 50
IN - India 44
FI - Finlandia 32
IE - Irlanda 32
CN - Cina 29
ID - Indonesia 22
DE - Germania 21
GB - Regno Unito 14
BG - Bulgaria 10
AT - Austria 8
BE - Belgio 7
FR - Francia 6
BJ - Benin 5
IR - Iran 5
RU - Federazione Russa 5
TG - Togo 5
NL - Olanda 4
AR - Argentina 3
RO - Romania 3
TR - Turchia 3
AU - Australia 2
CA - Canada 2
CH - Svizzera 2
MX - Messico 2
PH - Filippine 2
UA - Ucraina 2
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
SC - Seychelles 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.753
Città #
Fairfield 142
Rome 137
Singapore 109
Chandler 103
Ashburn 93
Seattle 66
Woodbridge 59
Houston 45
Wilmington 41
Cambridge 39
Santa Clara 34
Dublin 30
San Paolo di Civitate 25
Helsinki 23
Jakarta 22
Princeton 22
Ann Arbor 20
Lawrence 17
New York 16
Beijing 15
Millbury 13
New Orleans 12
Dearborn 11
Latina 10
Plano 10
San Diego 10
Sofia 10
Fremont 9
Miami 9
Boston 8
Milan 8
San Severo 8
Brussels 7
Bremen 6
Cagliari 6
Falls Church 6
Gainesville 6
Vienna 6
Andover 5
Cotonou 5
Hyderabad 5
Lomé 5
Norwalk 5
Boardman 4
London 4
Nottingham 4
Albano Laziale 3
Lappeenranta 3
Los Angeles 3
Munich 3
Pune 3
Redwood City 3
Tehran 3
Aversa 2
Bologna 2
Federal 2
Frankfurt am Main 2
Fuzhou 2
Genoa 2
Istanbul 2
L’Aquila 2
Mannheim 2
Moscow 2
Nuremberg 2
Perth 2
Pescara 2
Phoenix 2
San Mateo 2
Sassari 2
Stockholm 2
Termoli 2
Turin 2
Velletri 2
Washington 2
Aktobe 1
Aquila 1
Ariccia 1
Azcapotzalco 1
Bari 1
Bengaluru 1
Bern 1
Bethesda 1
Bolzano 1
Buffalo 1
Cachan 1
Caloocan City 1
Castel Maggiore 1
Catanzaro 1
Chengdu 1
Chiswick 1
Dallas 1
Damietta 1
Des Moines 1
Falkenstein 1
Fayetteville 1
Ghedi 1
Guangzhou 1
Guelph 1
Hanoi 1
Hefei 1
Totale 1.339
Nome #
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines 127
Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition 120
MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1 113
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 101
A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma 99
DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation 99
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 96
MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms 86
Altered expression of candidate genes in Mayer–Rokitansky–Küster–Hauser syndrome may influence vaginal keratinocytes biologya. A focus on Protein Kinase X 80
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization 78
Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines 75
BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells 73
Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. 73
Calcineurin gamma catalytic subunit ppp3cc inhibition by mir-200c-3p affects apoptosis in epithelial ovarian cancer 70
Expression levels and role of the de novo DNA methyltransferases in rhabdomyosarcoma 67
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance 67
OTX015 epi‐drug exerts antitumor effects in ovarian cancer cells by blocking GNL3‐mediated radioresistance mechanisms: cellular, molecular and computational evidence 66
Dnmt3a and dnmt3b targeting as an effective radiosensitizing strategy in embryonal rhabdomyosarcoma 65
Inhibiting DNA methylation as a strategy to enhance adipose-derived stem cells differentiation. Focus on the role of Akt/mTOR and Wnt/β-catenin pathways on adipogenesis 52
Assessing the Impact of Polyethylene Nano/Microplastic Exposure on Human Vaginal Keratinocytes 48
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 41
Translational implications for radiosensitizing strategies in rhabdomyosarcoma 33
Anti‑oncogenic and pro‑myogenic action of the MKK6/p38/AKT axis induced by targeting MEK/ERK in embryonal rhabdomyosarcoma 32
Hyperactive HRAS dysregulates energetic metabolism in fibroblasts from patients with Costello syndrome via enhanced production of reactive oxidizing species 31
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression 31
MS−275 (Entinostat) promotes radio-sensitivity in PAX3-FOXO1 rhabdomyosarcoma cells 29
Radioresistance in rhabdomyosarcomas: much more than a question of dose 23
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 18
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 12
Synergistic effects of PARP inhibitors and ionizing radiation on growth and survival of rhabdomyosarcoma cells 6
Totale 1.911
Categoria #
all - tutte 6.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020161 0 0 0 0 0 0 49 28 27 30 15 12
2020/2021191 7 14 25 8 5 13 1 3 24 65 17 9
2021/2022273 9 13 19 20 41 16 6 18 16 4 66 45
2022/2023396 37 76 30 41 38 36 4 36 69 3 23 3
2023/2024316 13 33 14 27 48 48 5 45 0 27 20 36
2024/2025276 21 45 41 61 39 69 0 0 0 0 0 0
Totale 1.911